MarketCap
Facebook
X
TelegramQuarterly report 2022-Q4
added 02-09-2023
Meridian Bioscience ROE Ratio 2011-2026 | VIVO
Annual ROE Ratio Meridian Bioscience
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11.54 | 21.75 | 18.65 | 12.77 | 13.6 | 12.71 | 19.36 | 21.43 | 21.58 | 24.53 | 23.38 | 19.37 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 24.53 | 11.54 | 18.39 |
Quarterly ROE Ratio Meridian Bioscience
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.59 | 19.79 | 15.74 | 19.36 | 19.31 | 20.84 | 23.47 | 29.71 | 31.69 | 23.52 | 23.05 | 15.76 | 7.59 | 10.69 | 11.64 | 12.89 | 15.99 | 15.1 | 15.38 | 11.7 | 10.81 | 10.95 | 10.87 | 15.99 | 16.12 | 17.6 | 19.41 | 19.64 | 21.23 | 20.87 | 20.84 | 20.84 | 20.39 | 20.19 | 21.01 | 22.08 | 23.78 | 25.19 | 25.3 | 24.76 | 24.09 | 22.74 | 21.58 | 20.49 | 19.3 | 4.84 | 4.93 | 4.75 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 31.69 | 4.75 | 17.93 |
ROE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-170.35 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Fulgent Genetics
FLGT
|
-3.77 | $ 15.96 | 5.63 % | $ 483 M |  USA |
 |
Burning Rock Biotech Limited
BNR
|
-43.17 | $ 16.76 | 1.09 % | $ 177 M |  China |
 |
Castle Biosciences
CSTL
|
-5.13 | $ 19.83 | 3.07 % | $ 575 M | USA |
 |
Agilent Technologies
A
|
22.45 | $ 115.62 | -2.55 % | $ 35.1 B | USA |
|
Akumin
AKU
|
325.23 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
184.36 | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
65.62 | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
-362.16 | - | -13.05 % | $ 7.29 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.85 | - | - | $ 562 M |  Britain |
 |
CareDx, Inc
CDNA
|
-7.05 | $ 21.82 | 1.77 % | $ 1.16 B | USA |
 |
Chembio Diagnostics
CEMI
|
-130.86 | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
1734.41 | - | - | $ 9.42 M |  Israel |
 |
Lantheus Holdings
LNTH
|
21.43 | $ 93.06 | 2.26 % | $ 6.28 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-400.51 | - | -20.0 % | $ 1.06 M | USA |
 |
Medpace Holdings
MEDP
|
98.27 | $ 424.0 | -1.1 % | $ 12.2 B | USA |
 |
Co-Diagnostics
CODX
|
-227.33 | $ 2.53 | 31.09 % | $ 3.37 M | USA |
 |
Myriad Genetics
MYGN
|
-99.46 | $ 4.29 | 4.89 % | $ 397 M | USA |
 |
NeoGenomics
NEO
|
-12.91 | $ 8.96 | -1.21 % | $ 1.15 B | USA |
 |
National Research Corporation
NRC
|
82.92 | $ 18.75 | 0.11 % | $ 420 M | USA |
 |
Global Cord Blood Corporation
CO
|
10.27 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
-38.13 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-43.4 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-181.33 | - | 0.12 % | $ 80.1 M | China |
 |
Natera
NTRA
|
-77.62 | $ 194.24 | -11.64 % | $ 19.1 B | USA |
 |
DermTech
DMTK
|
-176.45 | - | -11.32 % | $ 2.94 M | USA |
 |
Charles River Laboratories International
CRL
|
-4.56 | $ 177.62 | -2.23 % | $ 8.8 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
13.32 | - | - | $ 10.7 B | USA |
 |
Enzo Biochem
ENZ
|
-46.47 | - | -8.98 % | $ 14.8 K | USA |
 |
Koninklijke Philips N.V.
PHG
|
8.16 | $ 27.21 | 0.18 % | $ 25.8 B |  Niderland |
 |
Exact Sciences Corporation
EXAS
|
-8.66 | - | - | $ 19.8 B | USA |
 |
Personalis
PSNL
|
-31.12 | $ 5.98 | -0.17 % | $ 534 M | USA |
 |
Guardant Health
GH
|
419.21 | $ 95.7 | 3.73 % | $ 12 B | USA |
 |
Senseonics Holdings
SENS
|
-113.19 | $ 5.03 | -6.16 % | $ 210 M | USA |
 |
Soleno Therapeutics
SLNO
|
4.64 | $ 52.95 | - | $ 2.69 B | USA |
 |
Heska Corporation
HSKA
|
-4.71 | - | - | $ 1.31 B | USA |
 |
ICON Public Limited Company
ICLR
|
8.31 | $ 124.49 | -0.41 % | $ 10.3 B |  Irlanda |
 |
Illumina
ILMN
|
-51.54 | $ 141.88 | 2.29 % | $ 22.6 B | USA |
 |
Interpace Biosciences
IDXG
|
109.89 | $ 1.95 | -2.5 % | $ 8.63 M | USA |
 |
QIAGEN N.V.
QGEN
|
11.25 | - | - | $ 10.6 B | Niderland |
 |
Trinity Biotech plc
TRIB
|
88.73 | $ 0.61 | 2.52 % | $ 219 M | Irlanda |
 |
Twist Bioscience Corporation
TWST
|
-16.42 | $ 56.85 | -2.89 % | $ 3.4 B | USA |
 |
Biomerica
BMRA
|
-121.14 | $ 2.15 | -2.05 % | $ 4.94 M | USA |
 |
Thermo Fisher Scientific
TMO
|
12.55 | $ 465.0 | -1.99 % | $ 175 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
10.17 | $ 254.12 | -1.52 % | $ 21.1 B | USA |
 |
Celcuity
CELC
|
-176.06 | $ 131.06 | 0.27 % | $ 6.13 B | USA |
 |
Motus GI Holdings
MOTS
|
-478.86 | - | -34.28 % | $ 263 K | Israel |
 |
Waters Corporation
WAT
|
25.09 | $ 355.13 | 1.32 % | $ 21.1 B | USA |
 |
Neogen Corporation
NEOG
|
-52.72 | $ 9.05 | -2.16 % | $ 1.96 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
13.84 | $ 187.39 | -1.82 % | $ 20.8 B | USA |